Third-party Study Report: Investigation of Shear Stress Exerted on CHO Cell by Different Pump System
Exhibitor: LEVITRONIX GMBH TAIWAN BRANCH
Date: 2022-08-01
Booth No.: R1101
Mechanical Stress Analysis of Transfected CHO Suspension Cells – MagLev versus Peristaltic Pumps
Keywords:
- Bioprocessing
- Pump Comparison
- Peristaltic Pumps
- Shear Stress
- Cell Viability
Facts
In comparison to a Levitronix® pump, peristaltic pumps generate flow through tube compression along a pump casing. Tube compression can generate shear stress, which results in reduced cell viability.
Test conditions
One Levitronix® and two peristaltic pumps’ shear stress generation were compared by observing their effect on respective cell viabilities. 3.4 liters of CHO cells were introduced and pumped in three identical closed-loop configurations. The flow rate of each pump was set to 3.4 lpm and different backpressures for a period of over 400 minutes. The cell viability was measured at selected times and compared.
Results
The cell viability with the Levitronix® pump system was consistently above 95%. The peristaltic pumps reached cell viabilities of 70% and 28%, respectively. Similar results have been recorded at four different pressure levels up to 0.5 bar.
Time dependent viability of the cell suspension pumped with 3.4L/min without back pressure
Reference Details: Mechanical Stress Analysis of Transfected CHO Suspension Cells - MagLev versus Peristaltic Pumps - Levitronix (digtest.us)
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Mechanical Stress Analysis of Transfected CHO Suspension Cells – MagLev versus 4-Piston Diaphragm Pumps
Keywords:
- Bioprocessing
- Pump Comparison
- 4-Piston Diaphragm Pump
- Shear Stress
- Cell Viability
Facts
In comparison to a Levitronix® pump, a 4-Piston Diaphragm Pump consists of multiple valves that restrict fluid motion to the desired direction. Valve interaction can lead to shear stress, which can result in a reduced cell viability.
Test conditions
Two Levitronix® and one 4-Piston Diaphragm pumps’ shear stress generation were compared by observing their effect on respective cell viabilities. A fixed volume of CHO cells was pumped in three identical closed loop configurations. The flow rate of each pump was set to 3.4 lpm and backpressures of 0.03, 0.3, and 0.6 bar, respectively. The cell viability was measured at selected times and compared.
Results
Both Levitronix® pump systems revealed a significantly lower cell stress effect on CHO cells than compared to the 4-Piston Diaphragm Pump. Even at high speeds, the cell death rate was about 30% lower in the Levitronix® pumps than in the 4-Piston Diaphragm Pump.
Cell viability for all three pumps at 3.4 lpm and 0.03 bar
Reference Details: Mechanical Stress Analysis of Transfected CHO Suspension Cells - MagLev versus 4-Piston Diaphragm Pumps - Levitronix (digtest.us)
For more free public details, please click on the external related links below to check the Levitronix® official website.
More Exhibitor's Press Release
- Third-party Study Report: Investigation of Shear Stress Exerted on Proteins by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Third-party Study Report: Pump Particle Shedding Evaluation LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Bio Asia-Taiwan 2022 Opening! Vitae Biomedical showcases the new outstanding achievements. VITAE BIOMEDICAL CO. LTD. / 2022-07-30
- Joint Genomic Analytics Platform from Advantech, GARAOTUS and WASAI GARAOTUS (SYSTEX GROUP) / 2022-07-30
- FDA Grants the Pre-EUA Meeting Request by GoldenBiotech’s Applied Antroquinonol to Treat COVID GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Antroquinonol, Committed to Innovative & Breakthrough Therapy to Improve Quality of Life GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Italy participates for the third time in BIO ASIA with 7 companies ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2022-07-29
- AcadeMab makes its mark at 2022 BIO USA ACADEMAB BIOMEDICAL INC. / 2022-07-28
- Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutraliz ACADEMAB BIOMEDICAL INC. / 2022-07-28
- Home Visual Acuity tester- Don't let pseudomyopia become real myopia EYEMIKAN BIOTECH INC. / 2022-07-28
- CAMCEVI 42 mg Injection Emulsion Launched in the U.S. for the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- Foresee Announces European MAA Approval of CAMCEVI for the the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- TaiMed is your reliable biologics CDMO partner TAIMED BIOLOGICS INC. / 2022-07-27
- US FDA NDIN approval for Deglusterol, a new dietary ingredient for blood sugar control CAREGEN CO., LTD. / 2022-07-27
- 2022BioAsiaTaiwan-Golden Biotech Seminar Registration_Innovative Breakthrough_COVID-19 to Oncology GOLDEN BIOTECHNOLOGY CORP. / 2022-07-27
- Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan AMARAN BIOTECHNOLOGY, INC. / 2022-07-25
- "Montefarmaco’s portfolio covers the main segments of the self-medication market" MONTEFARMACO OTC SPA / 2022-07-22
- TMU BioMed Accelerator | 2022 Batch Demo Day (Register Now) TAIPEI MEDICAL UNIVERSITY / 2022-07-22
- BUCHI wins Swiss Export Award 2022 BUCHI TAIWAN CO., LTD. / 2022-07-21
- Automation and innovative design of BUCHI’s new Spray Dryer markedly improve spray drying performanc BUCHI TAIWAN CO., LTD. / 2022-07-21